These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20360317)

  • 1. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Amsterdam JD; Shults J
    Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
    Amsterdam JD; Shults J
    Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.
    Amsterdam JD; Luo L; Shults J
    Br J Psychiatry; 2013 Apr; 202(4):301-6. PubMed ID: 23099447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
    Amsterdam JD; Garcia-España F; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Schweizer E; Beasley C
    J Clin Psychopharmacol; 1998 Dec; 18(6):435-40. PubMed ID: 9864074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD; Luo L; Shults J
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term venlafaxine v. lithium monotherapy for bipolar type II major depressive episodes: effectiveness and mood conversion rate.
    Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
    Br J Psychiatry; 2016 Apr; 208(4):359-65. PubMed ID: 26892848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2010 Jun; 30(3):306-11. PubMed ID: 20473068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy.
    Amsterdam JD; Kim TT
    J Clin Psychopharmacol; 2019; 39(4):344-350. PubMed ID: 31205190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
    Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
    J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder.
    Calabrese JR; Pikalov A; Streicher C; Cucchiaro J; Mao Y; Loebel A
    Eur Neuropsychopharmacol; 2017 Sep; 27(9):865-876. PubMed ID: 28689688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate.
    Amsterdam JD; Shults J; Brunswick DJ; Hundert M
    Bipolar Disord; 2004 Feb; 6(1):75-81. PubMed ID: 14996144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
    Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
    J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
    Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
    Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.